Cardlytics chief legal officer sells $458 in stock

Published 23/04/2025, 01:32
Cardlytics chief legal officer sells $458 in stock

ATLANTA—Lynton Nicholas Hollmeyer, the Chief Legal & Privacy Officer at Cardlytics, Inc. (NASDAQ:CDLX), recently reported the sale of 303 shares of common stock, amounting to $458. The transaction, completed on April 22, 2025, was executed at a weighted average price of $1.513 per share. The shares were sold to cover tax withholding obligations resulting from the vesting of restricted stock units (RSUs).

On April 20, 2025, Hollmeyer also acquired 682 shares of common stock through the vesting of RSUs. This transaction was not associated with any purchase or sale consideration, as each RSU represents a contingent right to receive one share of common stock.

Following these transactions, Hollmeyer retains direct ownership of 102,119 shares of Cardlytics common stock.

In other recent news, Cardlytics reported fourth-quarter revenue of $74 million, surpassing its forecast of $64.29 million, despite a 16% year-over-year decline. The company achieved a positive adjusted EBITDA of $2.5 million for the full year, reflecting effective cost management. Analysts from Evercore ISI, Craig-Hallum, and BofA Securities adjusted their price targets for Cardlytics shares, with Evercore ISI and Craig-Hallum setting a target of $3.00 and BofA Securities lowering it to $2.50. Evercore ISI maintained an "In Line" rating, while Craig-Hallum and BofA Securities kept their Hold and Underperform ratings, respectively.

Cardlytics experienced significant product improvements, addressing previous issues of over-delivery and under-delivery, which led to better performance in the fourth quarter. The company also secured new partnerships, including a substantial neobank partnership and expanded its services to all American Express (NYSE:AXP) customers. Despite these advancements, challenges remain, with ongoing macroeconomic uncertainties affecting advertiser spending. Cardlytics’ management provided guidance for Q1 2025 billings between $91.5 million and $94.5 million, suggesting a gradual recovery throughout the year.

This article was generated with the support of AI and reviewed by an editor. For more information see our T&C.

Latest comments

Risk Disclosure: Trading in financial instruments and/or cryptocurrencies involves high risks including the risk of losing some, or all, of your investment amount, and may not be suitable for all investors. Prices of cryptocurrencies are extremely volatile and may be affected by external factors such as financial, regulatory or political events. Trading on margin increases the financial risks.
Before deciding to trade in financial instrument or cryptocurrencies you should be fully informed of the risks and costs associated with trading the financial markets, carefully consider your investment objectives, level of experience, and risk appetite, and seek professional advice where needed.
Fusion Media would like to remind you that the data contained in this website is not necessarily real-time nor accurate. The data and prices on the website are not necessarily provided by any market or exchange, but may be provided by market makers, and so prices may not be accurate and may differ from the actual price at any given market, meaning prices are indicative and not appropriate for trading purposes. Fusion Media and any provider of the data contained in this website will not accept liability for any loss or damage as a result of your trading, or your reliance on the information contained within this website.
It is prohibited to use, store, reproduce, display, modify, transmit or distribute the data contained in this website without the explicit prior written permission of Fusion Media and/or the data provider. All intellectual property rights are reserved by the providers and/or the exchange providing the data contained in this website.
Fusion Media may be compensated by the advertisers that appear on the website, based on your interaction with the advertisements or advertisers
© 2007-2025 - Fusion Media Limited. All Rights Reserved.